ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,078Medicare Part D Prescriptions Filled, Including Refills

Rank: 152 out of 1206

$477K Total Retail Price of All Prescriptions

Rank: 186 out of 1206

498 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 498 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 498 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 9,656 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 706 654 1 1
LEVOTHYROXINE SODIUM 436 388 2 2
OMEPRAZOLE 416 369 3 3
FUROSEMIDE 350 290 4 5
METFORMIN HCL 318 302 5 10
LISINOPRIL 313 297 6 4
WARFARIN SODIUM 304 281 7 8
POTASSIUM CHLORIDE 242 224 8 12
HYDROCHLOROTHIAZIDE 226 215 9 11
HYDROCODONE-ACETAMINOPHEN 223 170 S3 10 7
TRAMADOL HCL 215 184 11 17
AMLODIPINE BESYLATE 174 165 12 6
LOSARTAN POTASSIUM 170 143 13 20
METOPROLOL SUCCINATE 163 147 14 15
GLIMEPIRIDE 161 153 15 34
POLYETHYLENE GLYCOL 3350 159 145 16 31
SERTRALINE HCL 157 142 17 22
METOPROLOL TARTRATE 134 101 18 9
FLUOXETINE HCL 128 104 19 52
ALENDRONATE SODIUM 128 128 19 19
ATORVASTATIN CALCIUM 126 89 21 13
DONEPEZIL HCL 117 117 22 29
ATENOLOL 112 108 23 14
ALLOPURINOL 107 101 24 24
PREDNISONE 101 88 25 28
FENTANYL 101 88 S2 25 51
ZOLPIDEM TARTRATE 91 71 27 25
CITALOPRAM HBR 90 78 28 16
MELOXICAM 87 78 29 35
GABAPENTIN 87 68 29 18
TRAZODONE HCL 86 63 31 37
NAMENDA 85 73 32 36
DOXAZOSIN MESYLATE 82 82 33 75
AMIODARONE HCL 79 79 34 182
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 79 34 27
CARVEDILOL 75 75 36 32
FENOFIBRATE 75 46 36 56
SPIRONOLACTONE 73 53 38 41
TAMSULOSIN HCL 73 73 38 26
ISOSORBIDE MONONITRATE ER 69 69 40 40
ADVAIR DISKUS 60 42 41 55
JANUVIA 59 33 42 87
BUMETANIDE 55 54 43 101
BUSPIRONE HCL 54 34 44 110
TORSEMIDE 54 54 44 144
NEXIUM 54 54 44 47
CLONIDINE HCL 53 41 47 88
GEMFIBROZIL 52 28 48 71
MIRTAZAPINE 52 43 48 50
LANTUS 50 42 50 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 5, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.